Diabetes Mellitus, Type 1 Clinical Trials in Milan
5 recruitingMilan, Italy
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Diabetes Mellitus, Type 1
Eli Lilly and Company150 enrolled107 locationsNCT07222137
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
Eli Lilly and Company300 enrolled132 locationsNCT07222332
Recruiting
Phase 3
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia
Vertex Pharmaceuticals Incorporated52 enrolled29 locationsNCT04786262
Recruiting
TrialNet Pathway to Prevention of T1D
Diabetes Mellitus, Type 1
University of South Florida75,000 enrolled22 locationsNCT00097292
Recruiting
Not Applicable
Cardiovascular Risk Assessment in a Cohort of Italian Patients With Type 1 Diabetes Mellitus (CARDT1)
Cardiovascular DiseasesDiabetes Mellitus, Type 1
Centro Cardiologico Monzino200 enrolled2 locationsNCT06290544